We are live on ! Find out more
BG

Baupost Group Portfolio holdings

AUM $5.12B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+2.69%
1 Year Est. Return
+15.99%
3 Year Est. Return
+34.54%
5 Year Est. Return
+18.79%
10 Year Est. Return
+138.91%
AUM
$11B
AUM Growth
-$854M
Cap. Flow
-$1.24B
Cap. Flow %
-11.22%
Top 10 Hldgs %
70.17%
Holding
36
New
1
Increased
8
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$419M
2
XPO icon
XPO
XPO
+$88.3M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$73.1M
4
PARA
Paramount Global Class B
PARA
+$72.2M
5
LBTYA icon
Liberty Global Class A
LBTYA
+$65.5M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$377M
2
PXD
Pioneer Natural Resource Co.
PXD
+$305M
3
EBAY icon
eBay
EBAY
+$193M
4
SYF icon
Synchrony
SYF
+$169M
5
AGN
Allergan plc
AGN
+$151M

Sector Composition

Rank Sector Weight
1 Communication Services 28.89%
2 Healthcare 22.34%
3 Technology 15.28%
4 Consumer Discretionary 8.63%
5 Energy 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYK icon
1
Liberty Global Class C
LBTYK
$3.46B
$1.11B 10.07%
41,937,674
+2,844,679
+7% +$73.1M
VSAT icon
2
Viasat
VSAT
$9.74B
$1.11B 10.05%
13,732,068
– –
FOXA icon
3
Fox Class A
FOXA
$24.5B
$1B 9.06%
27,322,720
– –
EBAY icon
4
eBay
EBAY
$51.1B
$954M 8.63%
24,146,000
-5,140,000
-18% -$193M
LNG icon
5
Cheniere Energy
LNG
$54.1B
$731M 6.61%
10,674,135
-1,944,173
-15% -$129M
AGN
6
DELISTED
Allergan plc
AGN
$616M 5.58%
3,679,549
-1,090,146
-23% -$151M
BMY icon
7
Bristol-Myers Squibb
BMY
$130B
$590M 5.34%
13,000,000
+9,000,000
+225% +$419M
QRVO icon
8
Qorvo
QRVO
$8.01B
$578M 5.23%
8,681,181
-1,907,901
-18% -$133M
PCG icon
9
PG&E
PCG
$39.3B
$562M 5.08%
24,500,000
– –
PARA
10
DELISTED
Paramount Global Class B
PARA
$499M 4.52%
10,000,000
+1,457,984
+17% +$72.2M
MCK icon
11
McKesson
MCK
$106B
$349M 3.16%
2,595,011
-220,000
-8% -$27.4M
SYF icon
12
Synchrony
SYF
$24.7B
$321M 2.91%
9,260,557
-5,000,000
-35% -$169M
DBRG icon
13
DigitalBridge
DBRG
$2.93B
$248M 2.25%
12,421,843
– –
UNVR
14
DELISTED
Univar Solutions Inc.
UNVR
$209M 1.9%
9,500,000
– –
FOX icon
15
Fox Class B
FOX
$21.9B
$208M 1.88%
5,680,307
– –
LBTYA icon
16
Liberty Global Class A
LBTYA
$3.56B
$201M 1.82%
7,440,705
+2,483,500
+50% +$65.5M
COR icon
17
Cencora
COR
$62.5B
$189M 1.71%
2,214,192
-190,107
-8% -$15M
TAK icon
18
Takeda Pharmaceutical
TAK
$56.7B
$167M 1.51%
9,438,003
-1,231,018
-12% -$22.4M
AR icon
19
Antero Resources
AR
$10.9B
$158M 1.43%
28,587,791
– –
TBPH icon
20
Theravance Biopharma
TBPH
$875M
$152M 1.38%
9,309,168
– –
NXST icon
21
Nexstar Media Group
NXST
$5.96B
$141M 1.28%
1,397,755
+397,755
+40% +$42.7M
ATRA icon
22
Atara Biotherapeutics
ATRA
$70.3M
$141M 1.27%
280,000
+24,779
+10% +$17.5M
AKBA icon
23
Akebia Therapeutics
AKBA
$335M
$118M 1.07%
24,471,453
– –
TBIO
24
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$109M 0.99%
8,844,239
+2,352,941
+36% +$24.8M
XPO icon
25
XPO
XPO
$23.2B
$86.7M 0.78%
+4,337,091
New +$88.3M
1
2

Similar funds

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Baupost Group's Q2 2019 Portfolio in Review

As of Q2 2019, Baupost Group held 36 positions worth $11B, down 7.2% from $11.9B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Baupost Group withdrew a net $1.24B in Q2 2019, closing 4 positions and reducing 9 holdings. Its most notable exit was Celgene Corp, an estimated $377M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Baupost Group opened a new position in XPO worth $86.7M.

  • Baupost Group's largest Q2 2019 buy was XPO: 4,337,091 shares worth $86.7M.
  • Baupost Group added most to Bristol-Myers Squibb in Q2 2019, an estimated $419M increase.
  • Baupost Group's biggest Q2 2019 reduction was eBay, cutting an estimated $193M.
  • Baupost Group fully exited Celgene Corp in Q2 2019, selling an estimated $377M.
  • Baupost Group's ten largest holdings make up 70% of its $11B portfolio in Q2 2019.
  • Baupost Group opened 1 new position and closed 4 in Q2 2019.
  • Baupost Group's portfolio value fell 7.2% quarter-over-quarter to $11B.

Based on Baupost Group's 13F filing for Q2 2019, filed 13 Aug 2019.